Literature DB >> 10191251

Overexpression of an enzymically inactive interleukin-1-receptor-associated kinase activates nuclear factor-kappaB.

B Maschera1, K Ray, K Burns, F Volpe.   

Abstract

Upon interleukin 1 (IL-1) stimulation, the IL-1-receptor (IL-1R)-associated kinase (IRAK) is rapidly recruited to the IL-1R complex and undergoes phosphorylation. Here we demonstrate that recombinant wild-type IRAK (IRAK-WT), but not a kinase-defective mutant with Asp340 replaced by an asparagine residue (IRAK-Asp340Asn), is highly phosphorylated and is capable of auto-phosphorylation in vitro. Overexpression of both IRAK-WT and IRAK-Asp340Asn caused activation of nuclear factor kappaB, suggesting that the kinase activity of IRAK is not required outside of the IL-1R complex.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10191251      PMCID: PMC1220149     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

1.  Cytosolic domain of the type I interleukin-1 receptor spontaneously recruits signaling molecules to activate a proinflammatory gene.

Authors:  R Singh; S Huang; T Guth; M Konieczkowski; J R Sedor
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

Review 2.  The interleukin-1 receptor complex and interleukin-1 signal transduction.

Authors:  M U Martin; W Falk
Journal:  Eur Cytokine Netw       Date:  1997-03       Impact factor: 2.737

3.  Induction of the E-selectin promoter by interleukin 1 and tumour necrosis factor alpha, and inhibition by glucocorticoids.

Authors:  K P Ray; S Farrow; M Daly; F Talabot; N Searle
Journal:  Biochem J       Date:  1997-12-01       Impact factor: 3.857

4.  Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein.

Authors:  J Huang; X Gao; S Li; Z Cao
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

5.  IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling.

Authors:  M Muzio; J Ni; P Feng; V M Dixit
Journal:  Science       Date:  1997-11-28       Impact factor: 47.728

Review 6.  NF-kappaB activation: the I kappaB kinase revealed?

Authors:  I Stancovski; D Baltimore
Journal:  Cell       Date:  1997-10-31       Impact factor: 41.582

7.  MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1.

Authors:  N L Malinin; M P Boldin; A V Kovalenko; D Wallach
Journal:  Nature       Date:  1997-02-06       Impact factor: 49.962

8.  The interleukin-1 receptor-associated kinase is degraded by proteasomes following its phosphorylation.

Authors:  T T Yamin; D K Miller
Journal:  J Biol Chem       Date:  1997-08-22       Impact factor: 5.157

9.  The IL1 receptor accessory protein is responsible for the recruitment of the interleukin-1 receptor associated kinase to the IL1/IL1 receptor I complex.

Authors:  F Volpe; J Clatworthy; A Kaptein; B Maschera; A M Griffin; K Ray
Journal:  FEBS Lett       Date:  1997-12-08       Impact factor: 4.124

10.  TRAF6 is a signal transducer for interleukin-1.

Authors:  Z Cao; J Xiong; M Takeuchi; T Kurama; D V Goeddel
Journal:  Nature       Date:  1996-10-03       Impact factor: 49.962

View more
  17 in total

1.  IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase.

Authors:  Shyun Li; Astrid Strelow; Elizabeth J Fontana; Holger Wesche
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

2.  Regulation of Transforming Growth Factor β-Activated Kinase Activation by Epigallocatechin-3-Gallate in Rheumatoid Arthritis Synovial Fibroblasts: Suppression of K(63) -Linked Autoubiquitination of Tumor Necrosis Factor Receptor-Associated Factor 6.

Authors:  Anil K Singh; Sadiq Umar; Sharayah Riegsecker; Mukesh Chourasia; Salahuddin Ahmed
Journal:  Arthritis Rheumatol       Date:  2016-02       Impact factor: 10.995

3.  Interleukin-1 Receptor-Associated Kinase (IRAK) Signaling in Kaposi Sarcoma-Associated Herpesvirus-Induced Primary Effusion Lymphoma.

Authors:  Jedediah Seltzer; Razia Moorad; Jason M Schifano; Justin T Landis; Dirk P Dittmer
Journal:  J Virol       Date:  2020-05-04       Impact factor: 5.103

4.  The immunomodulating neuropeptide alpha-melanocyte-stimulating hormone (alpha-MSH) suppresses LPS-stimulated TLR4 with IRAK-M in macrophages.

Authors:  A W Taylor
Journal:  J Neuroimmunol       Date:  2005-05       Impact factor: 3.478

5.  Interleukin-1 (IL-1) receptor-associated kinase leads to activation of TAK1 by inducing TAB2 translocation in the IL-1 signaling pathway.

Authors:  G Takaesu; J Ninomiya-Tsuji; S Kishida; X Li; G R Stark; K Matsumoto
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

6.  Lipopolysaccharide-induced activation of beta2-integrin function in macrophages requires Irak kinase activity, p38 mitogen- activated protein kinase, and the Rap1 GTPase.

Authors:  A Schmidt; E Caron; A Hall
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

Review 7.  Pathogenesis of human B cell lymphomas.

Authors:  Arthur L Shaffer; Ryan M Young; Louis M Staudt
Journal:  Annu Rev Immunol       Date:  2012-01-06       Impact factor: 28.527

8.  Pathways regulating lipopolysaccharide-induced neutrophil survival revealed by lentiviral transduction of primary human neutrophils.

Authors:  Emily P Dick; Lynne R Prince; Elizabeth C Prestwich; Stephen A Renshaw; Moira K B Whyte; Ian Sabroe
Journal:  Immunology       Date:  2008-10-28       Impact factor: 7.397

9.  Lys63-linked polyubiquitination of IRAK-1 is required for interleukin-1 receptor- and toll-like receptor-mediated NF-kappaB activation.

Authors:  Dietrich B Conze; Chuan-Jin Wu; James A Thomas; Allison Landstrom; Jonathan D Ashwell
Journal:  Mol Cell Biol       Date:  2008-03-17       Impact factor: 4.272

10.  Surfactant lipids regulate LPS-induced interleukin-8 production in A549 lung epithelial cells by inhibiting translocation of TLR4 into lipid raft domains.

Authors:  Wondwossen Abate; Abdulaziz A Alghaithy; Joan Parton; Kenneth P Jones; Simon K Jackson
Journal:  J Lipid Res       Date:  2009-08-01       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.